Biological effects of a new ultraviolet A1 prototype based on light‐emitting diodes on the treatment of localized scleroderma

URN to cite this document:: urn:nbn:de:bvb:355-epub-445571
DOI to cite this document:: 10.5283/epub.44557

Arndt, Stephanie

; Lissner, Clara ; Unger, Petra ; Bäumler, Wolfgang ; Berneburg, Mark

; Karrer, Sigrid

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 26 Jan 2021 18:11

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Wiley.

Details

Preview

Indexed in

Export bibliographical data

Abstract

Ultraviolet A(1)(UVA(1)) phototherapy (spectral range 340-400 nm) is a well-established treatment option for various skin diseases such as localized scleroderma. Recent improvements of conventional UVA(1)light sources (metal-halide or fluorescent lamps) have brought attention to a new light-emitting diode (LED) technology with remarkable advantages in handling and clinical routine. This study ...